Table 4.
The percentages of treatment response and full remission post-4-week treatment between groups in 85 patients with major depressive disorder b,c
| |
Treatment response |
Full remission |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Groups |
Migraine |
Anxiety disorders |
Migraine |
Anxiety disorders |
||||||||
| Yes | No | OR (95% CI) | Yes | No | OR (95% CI) | Yes | No | OR (95% CI) | Yes | No | OR (95% CI) | |
| Bone and/or joints |
67.7 |
66.7 |
1.1 (0.3-3.9) |
70.8 |
63.6 |
1.4 (0.4-4.8) |
45.2 |
60.0 |
0.5 (0.2-1.9) |
45.8 |
54.5 |
0.7 (0.2-2.3) |
| Head |
45.5 |
60.7 |
0.5 (0.2-1.4) |
53.7 |
48.8 |
1.2 (0.5-3.1) |
11.4 |
39.3** |
0.2 (0.06-0.7) |
19.5 |
25.8 |
0.7 (0.2-2.1) |
| Back |
69.4 |
73.7 |
0.8 (0.2-2.8) |
73.3 |
68.0 |
1.3 (0.4-4.2) |
36.1 |
63.2a |
0.3 (0.1-1.0) |
40.0 |
52.0 |
0.6 (0.2-1.8) |
| Abdomen |
61.3 |
86.7a |
0.2 (0.05-1.3) |
58.3 |
81.8 |
0.3 (0.1-1.2) |
38.7 |
66.7 |
0.3 (0.1-1.2) |
33.3 |
63.6a |
0.3 (0.1-0.96) |
| Chest |
48.4 |
94.1** |
0.1 (0.01-0.5) |
65.4 |
63.6 |
1.1 (0.3-3.5) |
41.9 |
76.5* |
0.2 (0.06-0.8) |
53.8 |
54.5 |
0.97 (0.3-3.0) |
| Neck and/or shoulder |
46.5 |
60.6 |
0.6 (0.2-1.4) |
47.4 |
57.9 |
0.7 (0.3-1.6) |
7.0 |
39.4** |
0.1 (0.03-0.5) |
10.5 |
31.6* |
0.3 (0.1-0.9) |
| General muscle |
62.9 |
63.6 |
0.97 (0.3-2.9) |
63.3 |
63.0 |
1.0 (0.3-3.0) |
37.1 |
54.5 |
0.5 (0.2-1.5) |
33.3 |
55.6 |
0.4 (0.1-1.2) |
| Limbs | 62.5 | 90.0 | 0.2 (0.02-1.7) | 65.0 | 78.6 | 0.5 (0.1-2.4) | 41.7 | 70.0 | 0.3 (0.06-1.5) | 35.0 | 71.4a | 0.2 (0.05-0.95) |
*P <0.05; **P <0.01.
Abbreviation: CI confidence interval.
aBorderline significance (P =0.1-0.05).
bThe case numbers of the “migraine” and “anxiety disorders” groups were 44 (51.8%) and 43 (50.6%), respectively.
cTreatment response and full remission were defined as an improvement percentage of pain intensities > = 50 and =100, respectively.